87 related articles for article (PubMed ID: 22156497)
21. Importance of extended protease substrate recognition motifs in steering BNIP-2 cleavage by human and mouse granzymes B.
Van Damme P; Plasman K; Vandemoortele G; Jonckheere V; Maurer-Stroh S; Gevaert K
BMC Biochem; 2014 Sep; 15():21. PubMed ID: 25208769
[TBL] [Abstract][Full Text] [Related]
22. Extended substrate specificity of opossum chymase--implications for the origin of mast cell chymases.
Reimer JM; Enoksson M; Samollow PB; Hellman L
Mol Immunol; 2008 Apr; 45(7):2116-25. PubMed ID: 18022236
[TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of equine granzyme B.
Piuko K; Bravo IG; Müller M
Vet Immunol Immunopathol; 2007 Aug; 118(3-4):239-51. PubMed ID: 17604123
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis.
Le Bonniec BF; Myles T; Johnson T; Knight CG; Tapparelli C; Stone SR
Biochemistry; 1996 Jun; 35(22):7114-22. PubMed ID: 8679538
[TBL] [Abstract][Full Text] [Related]
25. Crystal structure of recombinant human tissue kallikrein at 2.0 A resolution.
Katz BA; Liu B; Barnes M; Springman EB
Protein Sci; 1998 Apr; 7(4):875-85. PubMed ID: 9568894
[TBL] [Abstract][Full Text] [Related]
26. The major human and mouse granzymes are structurally and functionally divergent.
Kaiserman D; Bird CH; Sun J; Matthews A; Ung K; Whisstock JC; Thompson PE; Trapani JA; Bird PI
J Cell Biol; 2006 Nov; 175(4):619-30. PubMed ID: 17116752
[TBL] [Abstract][Full Text] [Related]
27. Binding of amino acid side-chains to S1 cavities of serine proteinases.
Lu W; Apostol I; Qasim MA; Warne N; Wynn R; Zhang WL; Anderson S; Chiang YW; Ogin E; Rothberg I; Ryan K; Laskowski M
J Mol Biol; 1997 Feb; 266(2):441-61. PubMed ID: 9047374
[TBL] [Abstract][Full Text] [Related]
28. Extended intermolecular interactions in a serine protease-canonical inhibitor complex account for strong and highly specific inhibition.
Fodor K; Harmat V; Hetényi C; Kardos J; Antal J; Perczel A; Patthy A; Katona G; Gráf L
J Mol Biol; 2005 Jul; 350(1):156-69. PubMed ID: 15922357
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
Han S; Arvai AS; Clancy SB; Tainer JA
J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and kinetic studies of diphenyl 1-(N-peptidylamino)alkanephosphonate esters and their biotinylated derivatives as inhibitors of serine proteases and probes for lymphocyte granzymes.
Abuelyaman AS; Jackson DS; Hudig D; Woodard SL; Powers JC
Arch Biochem Biophys; 1997 Aug; 344(2):271-80. PubMed ID: 9264539
[TBL] [Abstract][Full Text] [Related]
31. Crystal structure of the human carboxypeptidase N (kininase I) catalytic domain.
Keil C; Maskos K; Than M; Hoopes JT; Huber R; Tan F; Deddish PA; Erdös EG; Skidgel RA; Bode W
J Mol Biol; 2007 Feb; 366(2):504-16. PubMed ID: 17157876
[TBL] [Abstract][Full Text] [Related]
32. The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase.
De Francesco R; Pessi A; Steinkühler C
Antivir Ther; 1998; 3(Suppl 3):99-109. PubMed ID: 10726060
[TBL] [Abstract][Full Text] [Related]
33. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
[TBL] [Abstract][Full Text] [Related]
34. Variability of the canonical loop conformations in serine proteinases inhibitors and other proteins.
Apostoluk W; Otlewski J
Proteins; 1998 Sep; 32(4):459-74. PubMed ID: 9726416
[TBL] [Abstract][Full Text] [Related]
35. A structural model for the prostate disease marker, human prostate-specific antigen.
Villoutreix BO; Getzoff ED; Griffin JH
Protein Sci; 1994 Nov; 3(11):2033-44. PubMed ID: 7535613
[TBL] [Abstract][Full Text] [Related]
36. Structural and kinetic analysis of caspase-3 reveals role for s5 binding site in substrate recognition.
Fang B; Boross PI; Tozser J; Weber IT
J Mol Biol; 2006 Jul; 360(3):654-66. PubMed ID: 16781734
[TBL] [Abstract][Full Text] [Related]
37. Crystal structure of phenylmethanesulfonyl fluoride-treated human chymase at 1.9 A.
McGrath ME; Mirzadegan T; Schmidt BF
Biochemistry; 1997 Nov; 36(47):14318-24. PubMed ID: 9400368
[TBL] [Abstract][Full Text] [Related]
38. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping.
Landro JA; Raybuck SA; Luong YP; O'Malley ET; Harbeson SL; Morgenstern KA; Rao G; Livingston DJ
Biochemistry; 1997 Aug; 36(31):9340-8. PubMed ID: 9235976
[TBL] [Abstract][Full Text] [Related]
39. Structure of granzyme C reveals an unusual mechanism of protease autoinhibition.
Kaiserman D; Buckle AM; Van Damme P; Irving JA; Law RH; Matthews AY; Bashtannyk-Puhalovich T; Langendorf C; Thompson P; Vandekerckhove J; Gevaert K; Whisstock JC; Bird PI
Proc Natl Acad Sci U S A; 2009 Apr; 106(14):5587-92. PubMed ID: 19299505
[TBL] [Abstract][Full Text] [Related]
40. Granzyme H destroys the function of critical adenoviral proteins required for viral DNA replication and granzyme B inhibition.
Andrade F; Fellows E; Jenne DE; Rosen A; Young CS
EMBO J; 2007 Apr; 26(8):2148-57. PubMed ID: 17363894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]